Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.5350
-0.0900 (-14.40%)
At close: Dec 24, 2025
Dimerix Market Cap
Dimerix has a market cap or net worth of 321.21 million as of December 26, 2025. Its market cap has increased by 57.76% in one year.
Market Cap
321.21M
Enterprise Value
253.03M
Revenue
5.59M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 321.21M, an increase of 2,326.73%. That is a compound annual growth rate of 35.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 321.21M | 69.35% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | 46.50M | 97.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 82.72B |
| Pro Medicus | 23.58B |
| Cochlear | 17.13B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.09B |
| Ansell | 5.05B |
| Telix Pharmaceuticals | 4.03B |
| Mesoblast | 3.72B |